Operating Income (Loss) in USD of Q32 Bio Inc. from Q1 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Q32 Bio Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2017 to Q3 2025.
  • Q32 Bio Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$7.58M, a 59.7% increase year-over-year.
  • Q32 Bio Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$43.5M, a 43.8% increase year-over-year.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2024 was -$66.1M, a 37% decline from 2023.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2023 was -$48.3M, a 63.8% increase from 2022.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2022 was -$133M, a 38.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Q32 Bio Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$43.5M -$7.58M +$11.2M +59.7% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$54.7M -$9.17M +$8.75M +48.8% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 -$63.5M -$12.2M +$2.62M +17.6% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$66.1M -$14.5M +$11.3M +43.7% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 -$77.4M -$18.8M -$11M -141% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$66.4M -$17.9M -$10.6M -146% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 -$55.7M -$14.8M -$7.47M -101% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$48.3M -$25.8M +$8.69M +25.2% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 -$56.9M -$7.8M +$25.1M +76.3% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$82M -$7.28M +$21M +74.3% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$103M -$7.37M +$30.2M +80.4% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$133M -$34.5M -$869K -2.58% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 -$132M -$32.9M -$2.2M -7.18% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$130M -$28.3M +$2.25M +7.35% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$132M -$37.6M -$36.5M -3286% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$95.9M -$33.6M -$3.82M -12.8% 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023
Q3 2021 -$92.1M -$30.7M -$2.39M -8.45% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$89.7M -$30.6M +$5.15M +14.4% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$94.9M -$1.11M +$35.4M +97% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$130M -$29.8M -$4.24M -16.6% 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2022
Q3 2020 -$126M -$28.3M +$3.02M +9.64% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$129M -$35.7M -$7.72M -27.6% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$121M -$36.5M -$11.4M -45.3% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 -$110M -$25.6M -$5.39M -26.7% 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 -$105M -$31.3M -$15.7M -100% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$88.9M -$28M -$14.6M -108% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 -$74.4M -$25.1M -$14.4M -135% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 -$59.9M -$20.2M -$7.91M -64.5% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 -$52M -$15.6M -$8.97M -135% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$43M -$13.4M -$7.38M -122% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 -$35.7M -$10.7M -$6M -128% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q4 2017 -$29.7M -$12.3M 01 Oct 2017 31 Dec 2017 10-K 12 Mar 2019
Q3 2017 -$6.66M 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018
Q2 2017 -$6.04M 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 -$4.69M 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018

Q32 Bio Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$66.1M -$17.8M -37% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 -$48.3M +$85M +63.8% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 -$133M -$37.3M -38.9% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 -$95.9M +$34.3M +26.3% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023
2020 -$130M -$20.3M -18.5% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022
2019 -$110M -$50M -83.5% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021
2018 -$59.9M -$30.3M -102% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020
2017 -$29.7M 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.